Corrigendum to ‘Inhibition of HDACs-EphA2 signaling axis with WW437 demonstrates promising preclinical antitumor activity in breast cancer’ [EBioMedicine 31 (2018) 276–286]Tao Zhang,Jingjie Li,Xiaojun Ma,Yang Yang,Wei Sun,Wangrui Jin,Lei Wang,Yuan He,Feifei Yang,Zhengfang Yi,Yingqi Hua,Mingyao Liu,Yihua Chen,Zhengdong CaiEBioMedicine(2020)引用 0|浏览26暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络